NO973421L - Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA - Google Patents

Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA

Info

Publication number
NO973421L
NO973421L NO973421A NO973421A NO973421L NO 973421 L NO973421 L NO 973421L NO 973421 A NO973421 A NO 973421A NO 973421 A NO973421 A NO 973421A NO 973421 L NO973421 L NO 973421L
Authority
NO
Norway
Prior art keywords
dna
recombinant dna
heavy chain
recombinant
myosin heavy
Prior art date
Application number
NO973421A
Other languages
English (en)
Other versions
NO973421D0 (no
Inventor
Kazuhide Hasegawa
Emi Arakawa
Shoji Oda
Yuzuru Matsuda
Katsuhito Talahashi
Haruo Ishiyama
Michihiro Sugahara
Original Assignee
Vessel Research Lab Co Ltd
Osaka Prefecture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vessel Research Lab Co Ltd, Osaka Prefecture filed Critical Vessel Research Lab Co Ltd
Publication of NO973421D0 publication Critical patent/NO973421D0/no
Publication of NO973421L publication Critical patent/NO973421L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives rekombinant DNA som omfatter DNA som koder for glattmuskel-type myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, en mikroorganisme som bærer den rekombinante DNA og et middel for behandling av arteriosklerose, som omfatter den rekombinante DNA. Denne rekombinante DNA kan benyttes effektivt som et middel ved genterapi ved restenose etter PTCA-behandling.
NO973421A 1995-01-25 1997-07-24 Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA NO973421L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1008595 1995-01-25
PCT/JP1996/000134 WO1996023069A1 (en) 1995-01-25 1996-01-25 Recombinant dna prepared by integrating dna that codes for myosin heavy-chain sm1 isoform protein into vector dna, and microorganism and arteriosclerosis remedy both containing the recombinant dna

Publications (2)

Publication Number Publication Date
NO973421D0 NO973421D0 (no) 1997-07-24
NO973421L true NO973421L (no) 1997-09-22

Family

ID=11740510

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973421A NO973421L (no) 1995-01-25 1997-07-24 Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA

Country Status (13)

Country Link
US (1) US6593304B1 (no)
EP (1) EP0806477B1 (no)
JP (1) JP3092944B2 (no)
KR (1) KR19980701695A (no)
AT (1) ATE236977T1 (no)
AU (1) AU711757B2 (no)
CA (1) CA2211468A1 (no)
DE (1) DE69627307T2 (no)
FI (1) FI973104L (no)
HU (1) HUP9801762A1 (no)
NO (1) NO973421L (no)
NZ (1) NZ300270A (no)
WO (1) WO1996023069A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11285333A (ja) * 1998-02-05 1999-10-19 Vessel Research Laboratory:Kk 変異型平滑筋ミオシン重鎖遺伝子を有する非ヒト動物の胚幹細胞および非ヒト動物
CN1321672A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人肌球蛋白重链12－14和编码这种多肽的多核苷酸
US6974688B2 (en) 2001-08-10 2005-12-13 Cytokinetics, Inc. Human smooth muscle myosin heavy chain
US10590452B2 (en) 2017-12-20 2020-03-17 University Of Seoul Industry Cooperation Foundation DNA-Mn hybrid particles and method of manufacturing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0646841A (ja) * 1992-07-24 1994-02-22 Kyowa Hakko Kogyo Co Ltd トランスフェリン非要求性細胞

Also Published As

Publication number Publication date
DE69627307T2 (de) 2004-03-04
JP3092944B2 (ja) 2000-09-25
FI973104A7 (fi) 1997-09-24
WO1996023069A1 (en) 1996-08-01
EP0806477B1 (en) 2003-04-09
NO973421D0 (no) 1997-07-24
ATE236977T1 (de) 2003-04-15
AU4496196A (en) 1996-08-14
DE69627307D1 (de) 2003-05-15
HUP9801762A1 (hu) 1998-11-30
NZ300270A (en) 1998-09-24
CA2211468A1 (en) 1996-08-01
AU711757B2 (en) 1999-10-21
EP0806477A4 (en) 2000-01-05
US6593304B1 (en) 2003-07-15
EP0806477A1 (en) 1997-11-12
FI973104L (fi) 1997-09-24
KR19980701695A (ko) 1998-06-25
FI973104A0 (fi) 1997-07-24

Similar Documents

Publication Publication Date Title
DE69434447D1 (de) Für die gentherapie verwendbare plasmide
NO981353D0 (no) Regulerte gener og anvendelser derav
TR199802676A2 (xx) T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem.
NO974824L (no) Arteriovenöse og venöse transplantasjonsbehandlinger, fremgangsmåter og blandinger
HUP9902867A3 (en) Therapeutic use of vegf protein or nucleic acid coding same and implant, especially for the treatment of intimal hyperplasia
AU2002311777A1 (en) Method of treating arthritis using lentiviral vectors in gene therapy
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
AU2225199A (en) Human suppressor trna oligonucleotides and methods of use for same
FI961666A7 (fi) Restenosiksen geeniterapia, jossa käytetään adenovirusvektoria
DK0687184T3 (da) Rekombinante adenoviruser og anvendelse deraf ved genterapi til behandling af øjensygdomme
DE69721824D1 (de) Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen
NO973421L (no) Rekombinant DNA omfattende DNA som koder for myosin tungkjede SM1-isoformt protein innskutt i vektor DNA, mikroorganisme som inneholder det rekombinante DNA og et middel for behandling av arteriosklerose omfattende det rekombinante DNA
WO1995027070A1 (de) Dna-expressionsvektoren zur verwendung in der gentherapeutischen behandlung von gefässerkrankungen
AU4037299A (en) Genetically-modified fibroblasts and the use thereof
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
NO981707L (no) Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav
ZA949807B (en) Regulatory nucleic acid sequences and uses
NO985558L (no) Ny forbedret formulering for behandling av tromboembolisme
ATE271878T1 (de) Verwendung von protein h als zytostattischer wirkstoff
AU2002252443A1 (en) Method of treating arthritis using lentiviral vectors in gene therapy
NZ505580A (en) Method of treating immunodeficiences using neutrokine alpha
ATE309354T1 (de) Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen
PT1133297E (pt) Nova aplicacao terapeutica da 1,6-dimetil-8beta-hidroximetil-10alfa-metoxiergolina
GB2333527A (en) Therapeutic gene